Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4611]

SABCS 2018: Circulating tumour cell count could help choose treatment for metastatic breast cancer patients

SABCS 2018: Circulating tumour cell count could help choose treatment for metastatic breast cancer patients

SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients with DCIS, LCIS, and ADH

SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients...

SABCS 2018: Delaying adjuvant chemotherapy associated with worse outcomes for patients with triple-negative breast cancer

SABCS 2018: Delaying adjuvant chemotherapy associated with worse outcomes for patients with triple-negative breast...

ASH 2018: Cancer patients show reduced risk of harmful clots while taking direct oral anticoagulants

ASH 2018: Cancer patients show reduced risk of harmful clots while taking direct oral anticoagulants

ASH 2018: Inhibiting the immune system’s natural response may boost benefits and sustainability of CAR T therapy

ASH 2018: Inhibiting the immune system’s natural response may boost benefits and sustainability of CAR T therapy

$ASH 2018: Longer term data validate durable responses with tisagenlecleucel in adults with relapsed and refractory DLBCL$

ASH 2018: Longer term data validate durable responses with tisagenlecleucel in adults with relapsed and refractory...

ASH 2018: Tisagenlecleucel continues to show durable remissions in kids and young adults with stubborn form of leukaemia

ASH 2018: Tisagenlecleucel continues to show durable remissions in kids and young adults with stubborn form of...

ASH 2018: CAR T-Cell therapies show durable responses, new research also explores combination therapies to extend and enhance treatment responses

ASH 2018: CAR T-Cell therapies show durable responses, new research also explores combination therapies to extend...

ASH 2018: Two studies suggest luspatercept reduces need for blood transfusions

ASH 2018: Two studies suggest luspatercept reduces need for blood transfusions

Altering cancer metabolism helps treatments attack tumours

Altering cancer metabolism helps treatments attack tumours

More from ecancer